Literature DB >> 28089340

Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.

Michele Sommariva1, Valentino Le Noci2, Chiara Storti3, Francesca Bianchi4, Elda Tagliabue5, Andrea Balsari6, Lucia Sfondrini7.   

Abstract

Controversies remain about NK cells direct responsiveness to Toll-like receptor (TLR) agonists or dependence on macrophages. In a melanoma lung metastasis model, aerosolized TLR9 and TLR3 agonists have been reported to induce antitumor immunity through NK cells activation. In the current study, we demonstrated that in vitro TLR9/TLR3 stimulation induced IFN-γ secretion by NK cells, but an increase in their cytotoxicity was detected only after NK cells co-culture with in vitro TLR9/TLR3 agonists pretreated alveolar macrophages. Alveolar macrophages from melanoma lung metastases-bearing mice, treated with aerosolized TLR agonists, also promoted NK cell cytotoxicity. Activated NK cells from lungs of melanoma metastases-bearing mice that were given aerosolized TLR9/TLR3 agonists were able to polarize naive alveolar macrophages toward a M1-like phenotype. Our results demonstrate that activation of NK cells in the lung after TLR engagement is mediated by alveolar macrophages and that activated NK cells shape macrophage behavior.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alveolar macrophages; Innate immunity; Lung; NK cells; Toll-like receptors

Mesh:

Substances:

Year:  2017        PMID: 28089340     DOI: 10.1016/j.cellimm.2017.01.004

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

1.  Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice.

Authors:  Shizhao Ma; Xinying Yang; Huifang Zhou; Chaoqun Zhang; Jiwen Kang; Dianxing Sun
Journal:  Onco Targets Ther       Date:  2020-07-20       Impact factor: 4.147

2.  Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.

Authors:  Amber Troy; Sandra C Esparza-Gonzalez; Alicia Bartek; Elizabeth Creissen; Linda Izzo; Angelo A Izzo
Journal:  Tuberculosis (Edinb)       Date:  2020-06-06       Impact factor: 3.131

3.  PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.

Authors:  Yui Hirata-Nozaki; Takayuki Ohkuri; Kenzo Ohara; Takumi Kumai; Marino Nagata; Shohei Harabuchi; Akemi Kosaka; Toshihiro Nagato; Kei Ishibashi; Kensuke Oikawa; Naoko Aoki; Mizuho Ohara; Yasuaki Harabuchi; Yuji Uno; Hidehiro Takei; Esteban Celis; Hiroya Kobayashi
Journal:  J Transl Med       Date:  2019-06-20       Impact factor: 5.531

4.  Aerosol 1,25-dihydroxyvitamin D3 supplementation: A strategy to boost anti-tumor innate immune activity.

Authors:  Francesca Bianchi; Michele Sommariva; Valentino Le Noci; Simone Camelliti; Nicoletta Gagliano; Marta Giussani; Andrea Balsari; Elda Tagliabue; Lucia Sfondrini
Journal:  PLoS One       Date:  2021-03-29       Impact factor: 3.240

5.  Immune-Mediated Mechanisms in Patients Testing Positive for SARS-CoV-2: Protocol for a Multianalysis Study.

Authors:  Lorenzo Mortara; Daniela Dalla Gasperina; Domenico Iovino; Giuseppe Ietto; Lorenzo Azzi; Andreina Baj; Walter Ageno; Angelo Paolo Genoni; Francesco Acquati; Matteo Gallazzi; Giorgia Spina; Grace Coco; Federica Pierin; Douglas Noonan; Andrea Vigezzi; Elisa Monti; Valentina Iori; Federica Masci; Caterina Franchi; Salomone Di Saverio; Giulio Carcano
Journal:  JMIR Res Protoc       Date:  2022-01-25

Review 6.  Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer.

Authors:  Yannick Degboé; Rémy Poupot; Mary Poupot
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

Review 7.  The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy.

Authors:  Michele Sommariva; Valentino Le Noci; Francesca Bianchi; Simone Camelliti; Andrea Balsari; Elda Tagliabue; Lucia Sfondrini
Journal:  Cell Mol Life Sci       Date:  2020-01-23       Impact factor: 9.261

8.  Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors.

Authors:  Edward Hammond; Nicole M Haynes; Carleen Cullinane; Todd V Brennan; Darryn Bampton; Paul Handley; Tomislav Karoli; Fleur Lanksheer; Liwen Lin; Yiping Yang; Keith Dredge
Journal:  J Immunother Cancer       Date:  2018-06-14       Impact factor: 13.751

9.  Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients.

Authors:  Francesca Bianchi; Massimo Milione; Patrizia Casalini; Giovanni Centonze; Valentino M Le Noci; Chiara Storti; Spyridon Alexiadis; Mauro Truini; Gabriella Sozzi; Ugo Pastorino; Andrea Balsari; Elda Tagliabue; Lucia Sfondrini
Journal:  Sci Rep       Date:  2019-10-03       Impact factor: 4.379

Review 10.  Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.

Authors:  Chloé Laplagne; Marcin Domagala; Augustin Le Naour; Christophe Quemerais; Dimitri Hamel; Jean-Jacques Fournié; Bettina Couderc; Corinne Bousquet; Audrey Ferrand; Mary Poupot
Journal:  Int J Mol Sci       Date:  2019-09-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.